The Intelligence Economy: Human-Guided AI for Pharma's Next Era

As LiveWorld marks its 30th anniversary and introduces LiveInsight AI™, Chairman and CEO Peter Friedman discusses why human-led, AI-powered intelligence systems are essential for pharma organizations navigating hallucination risk and regulatory scrutiny. He explains how pairing curated data, tailored AI, and human expertise turns raw information into decision-grade insight. Friedman also outlines what will separate pharma organizations that thrive in this new "intelligence economy" from those that fall behind.